CXCL14 is upregulated in glioblastoma, osteosarcoma, ovarian cancer, thyroid carcinoma, and endometrioid carcinoma, while downregulated in melanoma, colorectal cancer, and hepatocellular carcinoma [26]. This evidence concerns the gene CXCL14 and ovarian cancer.